richard kim, md, regarding targeted therapies in treatment of cholangiocarcinoma
Published 5 years ago • 105 plays • Length 1:16
Download video MP4
Download video MP3
Similar videos
-
0:43
richard kim, md, on the role of braf mutations in treatment of cholangiocarcinoma
-
1:14
richard kim, md, regarding the use of regorafenib in treatment of colorectal cancer
-
1:34
richard kim, md, on the use and sequencing of tkis in hepatocellular carcinoma (hcc)
-
1:17
richard kim, md, shares how we can utilize tkis in the management of hepatocellular carcinoma
-
19:03
ac21 - richard kim: which cholangiocarcinoma patients benefit from immunotherapy?
-
1:47
richard kim, md determines whether checkpoint inhibitors combine with regorafenib for hcc treatment
-
1:14
richard kim, md, discusses pembrolizumab as an effective agent in hcc management
-
1:24
rachna shroff, md, expands on targeted therapies in the treatment of cholangiocarcinoma
-
0:49
richard kim, md, considers the effectiveness of combination sorafenib and tace in hcc patients
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
1:26
richard kim, md, offers opinion on the redos study and dose escalation of regorafenib
-
42:04
non-surgical treatment options – richard kim, md, moffitt cancer center
-
1:34
richard kim, md, on results of phase 1 study regarding locally advanced rectal adenocarcioma
-
2:59
metastatic cholangiocarcinoma: targeted therapy and ngs
-
1:33
richard kim, md, offers analysis of the rainfall study in metastatic gastric & ge junction cancer
-
3:45
molecular target therapy in pancreatic and liver cancer
-
21:57
therapeutic management of biliary cancers: integrating precision medicine with targeted strategies
-
1:14:36
webinar: targeted treatment strategies for advanced cholangiocarcinoma -results of promising trials
-
1:25
richard finn, md, elaborates on current treatment options & sequencing of tkis in hcc
Clip.africa.com - Privacy-policy